Dongkwang Pharmaceutical Co., Ltd.

Republic of Korea

Back to Profile

1-1 of 1 for Dongkwang Pharmaceutical Co., Ltd. Sort by
Query
Aggregations
IPC Class
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives 1
A61K 36/232 - Angelica 1
A61K 36/233 - Bupleurum 1
A61K 36/234 - Cnidium (snowparsley) 1
A61K 36/53 - Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender 1
See more
Found results for  patents

1.

PHARMACEUTICAL COMPOSITION CONTAINING TILIANIN AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PARKINSON'S DISEASE

      
Application Number KR2018005458
Publication Number 2018/208128
Status In Force
Filing Date 2018-05-11
Publication Date 2018-11-15
Owner
  • UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (Republic of Korea)
  • INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (Republic of Korea)
  • DONGKWANG PHARMACEUTICAL CO., LTD. (Republic of Korea)
Inventor
  • Park, Seong Uk
  • Park, Hi-Joon
  • Jeon, Song Hee
  • Kim, Young Man
  • Cho, Seung Yeon
  • Ahn, Sora
  • Kim, Dong Hee
  • Jeong, Guwon
  • Oh, Seung Tack

Abstract

The present invention relates to a pharmaceutical composition and health functional food for prevention or treatment of Parkinson's disease, each containing a composite extract composed of Agastachis Herba containing tilianin, Paeonia lactiflora, Ligusticum chuanxiong, Angelica gigas, Bupleurum falcatum, Gardenia jasminoides, Paeonia suffruticosa, and Eugenia caryophyllata. The composition of the present invention improves behavioral disorders induced by MPTP and restores the loss of dopaminergic neurons, and thus has excellent effects in the prevention, alleviation, and treatment of Parkinson's disease.

IPC Classes  ?